Across the industry, from small biotechnology innovators to major multinational pharmaceutical corporations, life sciences companies rely on our prominent Life Sciences Foreign Corrupt Practice Act (FCPA) team to navigate the complex regulatory and enforcement environment that affects their operations across borders.

Our Life Sciences FCPA team is uniquely positioned to provide end-to-end support for our clients, from compliance counseling and program build-outs, to the efficient conduct of global internal investigations, and defense of companies before U.S. and international authorities, while keeping an appropriate eye towards the increasing risk of follow-on civil litigation.

As one of the few firms that regularly appears before the DOJ and SEC to handle FCPA-related investigations for life sciences companies, we support our clients with deep industry-specific expertise as they face these investigations, as well as help them implement post-resolution compliance responsibilities and monitorships.